When scientist J. Craig Venter and his team announced in 2010 that they had created the first cell controlled by a fully synthetic genome, it marked a turning point in how scientists think about life.

The Bay Area born agtech company has been beefing up its local research presence and already has a manufacturing facility in the region.

Scientists at Université de Montréal's Institute for Research in Immunology and Cancer have developed a new database that ...

For this action, the firm cited the potential of Nuvation Bio’s glioma drug candidate, safusidenib. First, RBC Capital ...

The news shows token-specific inflows: price up 5.8% while volume explodes ~697% to ~$200M+, and $0.03217 is the key pivot ...

Massive Bio, a leader in AI-enabled patient recruitment and oncology solutions, today announced a collaboration with OpenAI ...